Meyer Handelman Co. Acquires New Holdings in Cencora, Inc. $COR

Meyer Handelman Co. bought a new stake in Cencora, Inc. (NYSE:COR) during the first quarter, Holdings Channel.com reports. The firm bought 16,932 shares of the company’s stock, valued at approximately $5,319,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. Vestcor Inc increased its holdings in shares of Cencora by 0.5% during the third quarter. Vestcor Inc now owns 5,196 shares of the company’s stock worth $1,624,000 after buying an additional 28 shares in the last quarter. JFS Wealth Advisors LLC boosted its holdings in shares of Cencora by 30.2% during the 4th quarter. JFS Wealth Advisors LLC now owns 125 shares of the company’s stock valued at $42,000 after acquiring an additional 29 shares in the last quarter. Apollon Wealth Management LLC boosted its holdings in shares of Cencora by 0.5% during the 4th quarter. Apollon Wealth Management LLC now owns 6,527 shares of the company’s stock valued at $2,205,000 after acquiring an additional 30 shares in the last quarter. Accent Capital Management LLC grew its position in Cencora by 36.1% during the 4th quarter. Accent Capital Management LLC now owns 113 shares of the company’s stock worth $38,000 after acquiring an additional 30 shares during the last quarter. Finally, MCF Advisors LLC grew its position in Cencora by 11.0% during the 4th quarter. MCF Advisors LLC now owns 303 shares of the company’s stock worth $102,000 after acquiring an additional 30 shares during the last quarter. Institutional investors own 97.52% of the company’s stock.

Cencora Stock Up 1.1%

Shares of NYSE:COR opened at $287.55 on Friday. The firm has a market cap of $55.95 billion, a P/E ratio of 22.05, a P/E/G ratio of 1.53 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.95 and a debt-to-equity ratio of 3.40. Cencora, Inc. has a 12-month low of $244.82 and a 12-month high of $377.54. The business has a fifty day simple moving average of $281.44 and a 200 day simple moving average of $322.43.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, May 6th. The company reported $4.75 EPS for the quarter, missing the consensus estimate of $4.82 by ($0.07). Cencora had a return on equity of 135.20% and a net margin of 0.78%.The company had revenue of $78.36 billion for the quarter, compared to analyst estimates of $81.09 billion. During the same period in the previous year, the firm posted $4.42 earnings per share. The firm’s quarterly revenue was up 3.9% compared to the same quarter last year. Cencora has set its FY 2026 guidance at 17.650-17.900 EPS. Analysts predict that Cencora, Inc. will post 17.79 earnings per share for the current year.

Cencora declared that its Board of Directors has initiated a share buyback program on Thursday, May 21st that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 3.9% of its stock through open market purchases. Stock repurchase programs are often a sign that the company’s board believes its shares are undervalued.

Cencora Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend was Friday, May 15th. Cencora’s payout ratio is currently 18.40%.

Insider Buying and Selling

In related news, Director Lauren M. Tyler bought 550 shares of Cencora stock in a transaction that occurred on Monday, June 22nd. The shares were acquired at an average cost of $270.23 per share, for a total transaction of $148,626.50. Following the completion of the acquisition, the director directly owned 4,359 shares of the company’s stock, valued at approximately $1,177,932.57. The trade was a 14.44% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 0.38% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on COR shares. William Blair started coverage on Cencora in a report on Tuesday, April 28th. They issued a “market perform” rating for the company. Bank of America boosted their price target on Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a report on Wednesday. Evercore set a $360.00 price target on Cencora in a report on Wednesday, April 8th. Leerink Partners reaffirmed an “outperform” rating on shares of Cencora in a research note on Tuesday, March 17th. Finally, Morgan Stanley set a $342.00 price objective on shares of Cencora in a report on Friday, May 8th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cencora presently has an average rating of “Moderate Buy” and a consensus target price of $367.75.

Cencora Company Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.